Investigation of Early Hormonotherapy Efficacy of High Risk Patients for Progression of Prostate Cancer After Radical Prostatectomy
The primary purpose of this study is to evaluate the hypothesis, that early administration
of adjuvant hormonotherapy (triptorelin) can prolong survival data for high risk patients.
Control group (randomised study) will be treated with hormonotherapy, when PSA recidive
appear (on demand treatment). Secondary purposes will be to compare PSA dinamics and quality
of life data in the groups.
Allocation: Randomized, Endpoint Classification: Bio-equivalence Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Mindaugas Jievaltas, MD, PhD
Urology dep. of Kaunas University of Medicine
Lithuania: State Medicine Control Agency - Ministry of Health